Entrez ID	Gene Symbol	Gene Name	Refseq mRNA	Refseq Protein	Ensembl Gene ID	UCSC Genomic Coordinates	GO Categories	Sources
25	ABL1	v-abl Abelson murine leukemia viral oncogene homolog 1	NM_007313, NM_005157	NP_009297.2, NP_005148.2	ENSG00000097007	chr9:132579527 - 132750891	actin cytoskeleton organization and biogenesis;ATP binding;biological_process;cell adhesion;cellular_component;cytoplasm;cytoskeleton;DNA binding;DNA damage response, signal transduction resulting in induction of apoptosis;intracellular signaling cascade;magnesium ion binding;manganese ion binding;mismatch repair;molecular_function;nucleotide binding;nucleus;peptidyl-tyrosine phosphorylation;protein C-terminus binding;protein modification process;protein-tyrosine kinase activity;regulation of progression th	Alpha6Beta4 Integrin,  Kit Receptor,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Translocation
208	AKT2	v-akt murine thymoma viral oncogene homolog 2	NM_001626	NP_001617.1	ENSG00000105221	chr19:45431618 - 45463014	ATP binding;lamellipodium;nucleotide binding;protein amino acid phosphorylation;protein binding;protein modification process;protein serine/threonine kinase activity;regulation of JNK cascade;transferase activity	TNF_alpha_NF_kB,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Entrez Query:Oncogene,  Amplification
238	ALK	anaplastic lymphoma kinase (Ki-1)	NM_004304	NP_004295.2	ENSG00000171094	chr2:29269593 - 29997029	ATP binding;brain development;integral to plasma membrane;membrane;nervous system development;nucleotide binding;protein amino acid N-linked glycosylation;protein amino acid phosphorylation;receptor activity;receptor signaling protein tyrosine kinase activity;transferase activity;transmembrane receptor protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase signaling pathway	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tyrosine Kinase,  Translocation
324	APC	adenomatosis polyposis coli	NM_001127511, NM_001127510	NP_001120983.1, NP_001120982.1	ENSG00000134982	chr5:112118486 - 112207722	anterior/posterior pattern formation;axis specification;beta-catenin binding;beta-catenin destruction complex;cell adhesion;cell cycle;cell cycle arrest;centrosome;cytoplasm;dorsal/ventral pattern formation;kinetochore;lateral plasma membrane;microtubule binding;negative regulation of cell proliferation;negative regulation of cyclin-dependent protein kinase activity;negative regulation of microtubule depolymerization;nucleus;protein complex assembly;protein kinase binding;protein kinase CK2 regulator activi	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
472	ATM	ataxia telangiectasia mutated (includes complementation groups A, C and D)	NM_138292, NM_000051	NP_612149.1, NP_000042.3	ENSG00000149311	chr11:107603561 - 107741445	1-phosphatidylinositol-3-kinase activity;cell cycle;DNA binding;DNA repair;meiotic recombination;mitotic spindle checkpoint;negative regulation of progression through cell cycle;nucleus;protein N-terminus binding;protein serine/threonine kinase activity;response to ionizing radiation;signal transduction;transferase activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
8313	AXIN2	axin 2 (conductin, axil)	NM_004655	NP_004646.3	ENSG00000168646	chr17:60956555 - 60985200	intracellular;multicellular organismal development;nucleus;signal transducer activity;signal transduction;Wnt receptor signaling pathway	TGFBR,  Wnt,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability
581	BAX	BCL2-associated X protein	NM_138763, NM_004324, NM_138764, NM_138761, NM_138765	NP_620118.1, NP_004315.1, NP_620119.1, NP_620116.1, NP_620120.1	ENSG00000087088	chr19:54149997 - 54156166	apoptosis;apoptotic mitochondrial changes;B cell apoptosis;B cell homeostatic proliferation;BH3 domain binding;caspase activation;caspase activation via cytochrome c;cell cycle;cellular_component;cleavage of lamin;cytoplasm;cytosol;cytosolic part;DNA fragmentation during apoptosis;endoplasmic reticulum;endoplasmic reticulum membrane;establishment and/or maintenance of transmembrane electrochemical gradient;germ cell development;induction of apoptosis;induction of apoptosis by extracellular signals;induction	Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Entrez Query:Oncogene
596	BCL2	B-cell CLL/lymphoma 2	NM_000633, NM_000657	NP_000624.2, NP_000648.2	ENSG00000171791	chr18:58946837 - 59136879	anti-apoptosis;BH3 domain binding;cytoplasm;cytosol;defense response to virus;endoplasmic reticulum;humoral immune response;integral to membrane;membrane;mitochondrial outer membrane;mitochondrion;negative regulation of cellular pH reduction;negative regulation of mitochondrial depolarization;negative regulation of neuron apoptosis;neuron apoptosis;nuclear membrane;nucleus;pregnancy;protease binding;protein heterodimerization activity;protein homodimerization activity;regulation of mitochondrial membrane pe	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Translocation
604	BCL6	B-cell CLL/lymphoma 6 (zinc finger protein 51)	NM_001706	NP_001697.2	ENSG00000113916	chr3:188922939 - 188934175	actin cytoskeleton organization and biogenesis;B cell differentiation;cell morphogenesis;chromatin binding;DNA binding;erythrocyte development;germinal center formation;intracellular;metal ion binding;negative regulation of B cell apoptosis;negative regulation of cell differentiation;negative regulation of cell growth;negative regulation of cell proliferation;negative regulation of cell-matrix adhesion;negative regulation of isotype switching to IgE isotypes;negative regulation of mast cell cytokine product	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Missense mutation,  Translocation
641	BLM	Bloom syndrome	NM_000057	NP_000048.1	ENSG00000197299	chr15:89091626 - 89159513	ATP binding;ATP-dependent DNA helicase activity;DNA binding;DNA recombination;DNA repair;DNA replication;hydrolase activity;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;intracellular;nucleotide binding;nucleus;protein binding;regulation of binding;replication fork	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
657	BMPR1A	bone morphogenetic protein receptor, type IA	NM_004329	NP_004320.2	ENSG00000107779	chr10:88625755 - 88673456	anterior/posterior pattern formation;ATP binding;cartilage development;cell differentiation;dorsal/ventral axis specification;ectoderm development;heart development;hindlimb morphogenesis;integral to membrane;lung development;magnesium ion binding;manganese ion binding;membrane;mesendoderm development;Mullerian duct regression;nucleotide binding;positive regulation of epithelial cell proliferation;protein amino acid phosphorylation;receptor activity;SMAD binding;transferase activity;transforming growth fact	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
673	BRAF	v-raf murine sarcoma viral oncogene homolog B1	NM_004333	NP_004324.2	ENSG00000157764	chr7:140080865 - 140270972	anti-apoptosis;ATP binding;cytoplasm;diacylglycerol binding;intracellular signaling cascade;metal ion binding;nucleotide binding;organ morphogenesis;plasma membrane;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;receptor signaling protein activity;transferase activity;zinc ion binding	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
672	BRCA1	breast cancer 1, early onset	NM_007298, NM_007300, NM_007303, NM_007299, NM_007294, NM_007302, NM_007304, NM_007305	NP_009229.1, NP_009231.1, NP_009234.1, NP_009230.1, NP_009227.1, NP_009228.1, NP_009235.2, NP_009236.1	ENSG00000012048	chr17:38451220 - 38529639	androgen receptor binding;androgen receptor signaling pathway;BRCA1-BARD1 complex;cell cycle;cell cycle checkpoint;cellular_component;chromosome segregation;DNA binding;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;DNA damage response, signal transduction resulting in induction of apoptosis;DNA repair;enzyme binding;fatty acid biosynthetic process;gamma-tubulin ring complex;intracellular;metal ion binding;molecular_function;negative regulatio	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
675	BRCA2	breast cancer 2, early onset	NM_000059	NP_000050.2	ENSG00000139618	chr13:31788597 - 31870907	chromatin remodeling;cytoplasm;DNA repair;double-strand break repair via homologous recombination;establishment and/or maintenance of chromatin architecture;extracellular space;histone acetyltransferase activity;mitotic checkpoint;nucleus;protein binding;regulation of progression through cell cycle;regulation of S phase of mitotic cell cycle;regulation of transcription;secretory granule;single-stranded DNA binding;transcriptional activator activity	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
595	CCND1	cyclin D1	NM_053056	NP_444284.1	ENSG00000110092	chr11:69165262 - 69175231	cell cycle;cell division;cellular_component;cyclin-dependent protein kinase holoenzyme complex;cyclin-dependent protein kinase regulator activity;cytosol;fat cell differentiation;G1/S transition of mitotic cell cycle;intracellular;nucleus;protein amino acid phosphorylation;protein binding;protein kinase activity;re-entry into mitotic cell cycle;unfolded protein response	Androgen Receptor,  TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Entrez Query:Oncogene,  Translocation
79577	CDC73	cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)	NM_024529	NP_078805.3	ENSG00000134371	chr1:191357953 - 191486465	cell cycle;negative regulation of progression through cell cycle;nucleus;protein binding;transcription	Vogelstein and Kinzler 2004,  Tumor Suppressor,  Entrez Query:Oncogene
999	CDH1	cadherin 1, type 1, E-cadherin (epithelial)	NM_004360	NP_004351.1	ENSG00000039068	chr16:67328819 - 67424903	calcium ion binding;cell adhesion;homophilic cell adhesion;integral to membrane;membrane;molecular_function;protein binding	Wnt,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
1019	CDK4	cyclin-dependent kinase 4	NM_000075	NP_000066.1	ENSG00000135446	chr12:56428574 - 56431767	ATP binding;cell cycle;cell division;cell proliferation;cyclin-dependent protein kinase activity;G1/S transition of mitotic cell cycle;nucleotide binding;nucleus;protein amino acid phosphorylation;protein binding;protein kinase activity;regulation of progression through cell cycle;transferase activity	TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Missense mutation
1029	CDKN2A	cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)	NM_000077, NM_058197, NM_058195	NP_000068.1, NP_478104.2, NP_478102.1	ENSG00000147889	chr9:21961001 - 21984453	apoptosis;cell aging;cell cycle;cell cycle arrest;cell cycle checkpoint;cellular_component;cyclin-dependent protein kinase inhibitor activity;cytoplasm;DNA binding;epidermis development;negative regulation of cell proliferation;negative regulation of cyclin-dependent protein kinase activity;nucleolus;nucleoplasm;nucleus;protein binding;regulation of cyclin-dependent protein kinase activity;regulation of transcription, DNA-dependent;rRNA processing;transcription	Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
1499	CTNNB1	catenin (cadherin-associated protein), beta 1, 88kDa	NM_001904	NP_001895.1	ENSG00000168036	chr3:41240563 - 41255837	alpha-catenin binding;androgen receptor binding;androgen receptor signaling pathway;apical part of cell;basolateral plasma membrane;beta-catenin destruction complex;binding;bone resorption;cadherin binding;cell fate determination;cell fate specification;cell maturation;cell-cell adherens junction;cell-cell adhesion;cellular morphogenesis during differentiation;chromatin binding;cytoplasm;cytoskeleton;dorsal/ventral axis specification;ectoderm development;embryonic arm morphogenesis;embryonic digit morphogen	Androgen Receptor,  TGFBR,  Wnt,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
1540	CYLD	cylindromatosis (turban tumor syndrome)	NM_001042412, NM_015247	NP_001035877.1, NP_056062.1	ENSG00000083799	chr16:49341110 - 49387920	cell cycle;cysteine-type peptidase activity;cytoskeleton;intracellular;negative regulation of progression through cell cycle;ribosome;structural constituent of ribosome;translation;ubiquitin cycle;ubiquitin thiolesterase activity;ubiquitin-dependent protein catabolic process	TNF_alpha_NF_kB,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
1643	DDB2	damage-specific DNA binding protein 2, 48kDa	NM_000107	NP_000098.1	ENSG00000134574	chr11:47193263 - 47216976	damaged DNA binding;nucleotide-excision repair;nucleus;protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Entrez Query:Oncogene,  Missense mutation,  Nonsense mutation
1956	EGFR	epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)	NM_201284, NM_005228, NM_201283, NM_201282	NP_958441.1, NP_005219.2, NP_958440.1, NP_958439.1	ENSG00000146648	chr7:55054464 - 55240804	actin filament binding;AP-2 adaptor complex;ATP binding;calcium-dependent phospholipase A2 activation;cell cycle;cell proliferation;cell surface receptor linked signal transduction;cell-cell adhesion;cytoplasm;double-stranded DNA binding;endosome;epidermal growth factor receptor activity;epidermal growth factor receptor signaling pathway;extracellular space;identical protein binding;integral to membrane;MAP/ERK kinase kinase activity;negative regulation of progression through cell cycle;nitric-oxide synthas	Alpha6Beta4 Integrin,  EGFR1,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Amplification,  Missense mutation
2048	EPHB2	EPH receptor B2	NM_017449, NM_004442	NP_059145.2, NP_004433.2	ENSG00000133216	chr1:22910062 - 23112650	ATP binding;ephrin receptor activity;integral to membrane;membrane;nervous system development;nucleotide binding;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activity;receptor activity;synapse;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathway;transmembrane-ephrin receptor activity	Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Tyrosine Kinase
2064	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)	NM_001005862, NM_004448	NP_001005862.1, NP_004439.2	ENSG00000141736	chr17:35110017 - 35137823	apical plasma membrane;ATP binding;cell proliferation;cytoplasm;epidermal growth factor receptor activity;ErbB-3 class receptor binding;extracellular region;heart development;identical protein binding;integral to membrane;mammary gland development;membrane;myelination;non-membrane spanning protein tyrosine kinase activity;nucleotide binding;peripheral nervous system development;phosphoinositide-mediated signaling;plasma membrane;positive regulation of epithelial cell proliferation;positive regulation of MAP	Alpha6Beta4 Integrin,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Amplification
2068	ERCC2	excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)	NM_000400	NP_000391.1	ENSG00000104884	chr19:50546726 - 50565638	5' to 3' DNA helicase activity;aging;ATP binding;ATP-dependent DNA helicase activity;DNA binding;holo TFIIH complex;hydrolase activity;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;induction of apoptosis;magnesium ion binding;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;nucleotide binding;nucleotide-excision repair;nucleus;post-embryonic development;protein binding;regulation of transcription, DNA-dependent;response to oxidative stress;sensory pe	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
2073	ERCC5	excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome))	NM_000123	NP_000114.2	ENSG00000134899	chr13:102257618 - 102322747	DNA binding;DNA repair;endodeoxyribonuclease activity;endonuclease activity;hydrolase activity;nuclease activity;nucleotide-excision repair;nucleus;sensory perception of sound;single-stranded DNA binding;transcription-coupled nucleotide-excision repair	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Frameshift mutation,  Missense mutation,  Nonsense mutation
2122	EVI1	ecotropic viral integration site 1	NM_005241, NM_001105077	NP_005232.2, NP_001098547.2	ENSG00000085276	chr3:170285390 - 170345481	biological_process;DNA binding;intracellular;metal ion binding;molecular_function;multicellular organismal development;nucleic acid binding;nucleus;positive regulation of transcription from RNA polymerase II promoter;regulation of cell proliferation;zinc ion binding	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Translocation
2130	EWSR1	Ewing sarcoma breakpoint region 1	NM_005243, NM_013986	NP_005234.1, NP_053733.1	ENSG00000182944	chr22:27994325 - 28026151	calmodulin binding;intracellular;metal ion binding;nucleic acid binding;nucleotide binding;nucleus;regulation of transcription, DNA-dependent;RNA binding;transcription;zinc ion binding	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Translocation
2131	EXT1	exostoses (multiple) 1	NM_000127	NP_000118.2	ENSG00000182197	chr8:118881131 - 119192466	cell cycle;endoderm development;endoplasmic reticulum;endoplasmic reticulum membrane;gastrulation;glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;glycosaminoglycan biosynthetic process;Golgi apparatus;heparan sulfate proteoglycan biosynthetic process;integral to endoplasmic reticulum membrane;integral to membrane;membrane;mesoderm development;N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity;negative regulation of progression through ce	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
2132	EXT2	exostoses (multiple) 2	NM_207122	NP_997005.1	ENSG00000151348	chr11:44085838 - 44222413	cell cycle;endoplasmic reticulum;endoplasmic reticulum membrane;glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity;glycosaminoglycan biosynthetic process;Golgi apparatus;integral to membrane;membrane;N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity;negative regulation of progression through cell cycle;protein binding;signal transduction;skeletal development;transferase activity, transferring glycosyl groups	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
2175	FANCA	Fanconi anemia, complementation group A	NM_001018112, NM_000135	NP_001018122.1, NP_000126.2	ENSG00000187741	chr16:88332509 - 88410524	cytoplasm;DNA repair;nucleus;protein binding;protein complex assembly	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
2176	FANCC	Fanconi anemia, complementation group C	NM_000136	NP_000127.2	ENSG00000158169	chr9:96903809 - 97051394	cytoplasm;cytosol;DNA repair;germ cell development;nucleotide-excision repair;nucleus;protein binding;protein complex assembly	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
2177	FANCD2	Fanconi anemia, complementation group D2	NM_001018115, NM_033084	NP_001018125.1, NP_149075.2	ENSG00000144554	chr3:10045341 - 10115634	biological_process;cell cycle;cellular_component;condensed chromosome;DNA repair;molecular_function;nucleus;protein binding	TNF_alpha_NF_kB,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation
2178	FANCE	Fanconi anemia, complementation group E	NM_021922	NP_068741.1	ENSG00000112039	chr6:35528300 - 35542100	DNA repair;molecular_function;nucleus;protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Nonsense mutation,  Splicing mutation
2188	FANCF	Fanconi anemia, complementation group F	NM_022725	NP_073562.1	ENSG00000183161	chr11:22602807 - 22603932	biological_process;cellular_component;DNA repair;molecular_function;nucleus;protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Nonsense mutation
2189	FANCG	Fanconi anemia, complementation group G	NM_004629	NP_004620.1	ENSG00000165281	chr9:35064104 - 35069521	binding;cell cycle checkpoint;damaged DNA binding;DNA repair;nucleus;ovarian follicle development;response to radiation;spermatid development	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
355	FAS	Fas (TNF receptor superfamily, member 6)	NM_152875, NM_152877, NM_000043, NM_152872, NM_152874, NM_152871, NM_152876	NP_690614.1, NP_690616.1, NP_000034.1, NP_690611.1, NP_690613.1, NP_690610.1, NP_690615.1	ENSG00000026103	chr10:90740613 - 90764187	anti-apoptosis;apoptosis;cytosol;identical protein binding;immune response;induction of apoptosis;integral to membrane;membrane;protein binding;protein complex assembly;regulation of apoptosis;signal transduction;soluble fraction;transmembrane receptor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Missense mutation
55294	FBXW7	F-box and WD repeat domain containing 7	NM_001013415, NM_033632, NM_018315	NP_001013433.1, NP_361014.1, NP_060785.2	ENSG00000109670	chr4:153463482 - 153552405	nucleus;protein binding;protein ubiquitination	NOTCH,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Missense mutation,  Nonsense mutation
2242	FES	feline sarcoma oncogene	NM_002005	NP_001996.1	ENSG00000182511	chr15:89229279 - 89239792	ATP binding;cell proliferation;intracellular signaling cascade;multicellular organismal development;nucleotide binding;protein amino acid phosphorylation;protein-tyrosine kinase activity;transferase activity	Kit Receptor,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tyrosine Kinase,  Entrez Query:Oncogene
2260	FGFR1	fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome)	NM_023108, NM_023105, NM_023110, NM_023106, NM_023107, NM_015850	NP_075596.1, NP_075593.1, NP_075598.2, NP_075594.1, NP_075595.1, NP_056934.2	ENSG00000077782	chr8:38390302 - 38434121	ATP binding;cell growth;fibroblast growth factor receptor activity;fibroblast growth factor receptor signaling pathway;heparin binding;integral to plasma membrane;MAPKKK cascade;membrane;membrane fraction;nucleotide binding;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activity;receptor activity;skeletal development;transferase activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tyrosine Kinase,  Entrez Query:Oncogene,  Translocation
2263	FGFR2	fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome)	NM_000141, NM_022970	NP_000132.3, NP_075259.4	ENSG00000066468	chr10:123229360 - 123343321	ATP binding;cell growth;cell surface;fibroblast growth factor receptor activity;heparin binding;integral to membrane;membrane;nucleotide binding;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activity;receptor activity;transferase activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
2261	FGFR3	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)	NM_022965, NM_000142	NP_075254.1, NP_000133.1	ENSG00000068078	chr4:1765459 - 1778787	ATP binding;cell growth;fibroblast growth factor receptor activity;fibroblast growth factor receptor signaling pathway;identical protein binding;integral to plasma membrane;JAK-STAT cascade;MAPKKK cascade;membrane;nucleotide binding;protein amino acid phosphorylation;protein-tyrosine kinase activity;receptor activity;skeletal development;transferase activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tyrosine Kinase,  Missense mutation,  Translocation
2271	FH	fumarate hydratase	NM_000143	NP_000134.2	ENSG00000091483	chr1:239727750 - 239749645	cell cycle;cytoplasm;fumarate hydratase activity;fumarate metabolic process;lyase activity;mitochondrion;negative regulation of progression through cell cycle;tricarboxylic acid cycle;tricarboxylic acid cycle enzyme complex	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
201163	FLCN	folliculin	NM_144606, NM_144997	NP_653207.1, NP_659434.2	ENSG00000154803	chr17:17057693 - 17072176	cell cycle;negative regulation of progression through cell cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
2322	FLT3	fms-related tyrosine kinase 3	NM_004119	NP_004110.2	ENSG00000122025	chr13:27476188 - 27572647	ATP binding;integral to plasma membrane;lymphocyte differentiation;membrane;nucleotide binding;positive regulation of cell proliferation;protein amino acid phosphorylation;protein binding;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathway;vascular endothelial growth factor receptor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Tyrosine Kinase,  Missense mutation
2324	FLT4	fms-related tyrosine kinase 4	NM_182925, NM_002020	NP_891555.2, NP_002011.2	ENSG00000037280	chr5:179962797 - 180009151	ATP binding;integral to plasma membrane;membrane;nucleotide binding;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activity;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathway;vascular endothelial growth factor receptor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tyrosine Kinase,  Missense mutation
2308	FOXO1	forkhead box O1	NM_002015	NP_002006.2	ENSG00000150907	chr13:40031659 - 40138349	anti-apoptosis;blood vessel development;cytoplasm;insulin receptor signaling pathway;nucleus;positive regulation of transcription from RNA polymerase II promoter;protein binding;regulation of cell proliferation;regulation of transcription, DNA-dependent;sequence-specific DNA binding;transcription;transcription factor activity;transcriptional activator activity	EGFR1,  TGFBR,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Translocation
2309	FOXO3	forkhead box O3	NM_201559	NP_963853.1	ENSG00000118689	chr6:108989104 - 109092751	antral ovarian follicle growth;apoptosis;cytoplasm;glucose homeostasis;induction of apoptosis;initiation of primordial ovarian follicle growth;membrane fraction;nucleus;oocyte maturation;ovulation (sensu Mammalia);positive regulation of erythrocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;protein kinase binding;regulation of transcription, DNA-dependent;response to DNA damage stimulus;sequence-specific DNA binding;transcription;transcription factor activity;transc	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Translocation
2735	GLI1	glioma-associated oncogene homolog 1 (zinc finger protein)	NM_005269	NP_005260.1	ENSG00000111087	chr12:56143741 - 56152111	cerebellar cortex morphogenesis;chromatin binding;cytoplasm;DNA binding;dorsal/ventral pattern formation;epidermal cell differentiation;intracellular;lung development;metal ion binding;microtubule binding;multicellular organismal development;notochord development;nucleus;osteoblast differentiation;pituitary gland development;positive regulation of cell proliferation;positive regulation of DNA replication;positive regulation of transcription;positive regulation of transcription from RNA polymerase II promote	Hedgehog,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene
2719	GPC3	glypican 3	NM_004484	NP_004475.1	ENSG00000147257	chrX:132497817 - 132947142	GPI anchor binding;integral to plasma membrane;membrane;negative regulation of cell proliferation;negative regulation of growth;organ morphogenesis;positive regulation of BMP signaling pathway;proteinaceous extracellular matrix;ureteric bud branching	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation,  Translocation
8091	HMGA2	high mobility group AT-hook 2	NM_003483, NM_003484	NP_003474.1, NP_003475.1	ENSG00000149948	chr12:64505317 - 64643339	AT DNA binding;chromatin;chromosome;chromosome organization and biogenesis (sensu Eukaryota);DNA binding;establishment and/or maintenance of chromatin architecture;multicellular organismal development;nucleus;protein binding;regulation of transcription, DNA-dependent;transcription	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Translocation
3207	HOXA11	homeobox A11	NM_005523	NP_005514.1	ENSG00000005073	chr7:27188939 - 27191288	anatomical structure morphogenesis;induction of an organ;metanephros development;multicellular organismal development;nucleus;protein binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding;skeletal development;transcription factor activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
3209	HOXA13	homeobox A13	NM_000522	NP_000513.2	ENSG00000106031	chr7:27204341 - 27206221	multicellular organismal development;nucleus;protein binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding;skeletal development;transcription factor activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
3205	HOXA9	homeobox A9	NM_152739	NP_689952.1	ENSG00000078399	chr7:27169746 - 27171601	biological_process;molecular_function;multicellular organismal development;nucleus;protein binding;regulation of transcription, DNA-dependent;sequence-specific DNA binding;transcription factor activity;transcriptional activator activity	TGFBR,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
3229	HOXC13	homeobox C13	NM_017410	NP_059106.2	ENSG00000123364	chr12:52618957 - 52625307	anatomical structure morphogenesis;multicellular organismal development;nucleus;regulation of transcription, DNA-dependent;RNA polymerase II transcription factor activity;sequence-specific DNA binding;transcription factor activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
3237	HOXD11	homeobox D11	NM_021192	NP_067015.2	ENSG00000128713	chr2:176680329 - 176682116	induction of an organ;metanephros development;multicellular organismal development;nucleus;regulation of transcription, DNA-dependent;sequence-specific DNA binding;skeletal development;transcription factor activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
3239	HOXD13	homeobox D13	NM_000523	NP_000514.2	ENSG00000128714	chr2:176665864 - 176667704	embryonic limb morphogenesis;nucleus;pattern specification process;regulation of cell proliferation;regulation of transcription, DNA-dependent;sequence-specific DNA binding;skeletal development;transcription factor activity;transcription from RNA polymerase II promoter	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
3717	JAK2	Janus kinase 2 (a protein tyrosine kinase)	NM_004972	NP_004963.1	ENSG00000096968	chr9:5011987 - 5116791	apoptosis;ATP binding;cell motility;cytoskeleton;intracellular signaling cascade;Janus kinase activity;mesoderm development;myeloid cell differentiation;negative regulation of cell proliferation;nucleotide binding;protein amino acid phosphorylation;protein-tyrosine kinase activity;receptor binding;regulation of progression through cell cycle;SH2 domain binding;STAT protein nuclear translocation;transferase activity;tyrosine phosphorylation of STAT protein	EGFR1,  Kit Receptor,  NOTCH,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Translocation
3815	KIT	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog	NM_000222, NM_001093772	NP_000213.1, NP_001087241.1	ENSG00000157404	chr4:55218938 - 55299480	ATP binding;cytokine and chemokine mediated signaling pathway;external side of plasma membrane;hemopoiesis;integral to membrane;membrane;nucleotide binding;peptidyl-tyrosine phosphorylation;pigmentation during development;protein amino acid dephosphorylation;protein binding;protein kinase cascade;receptor activity;receptor signaling protein tyrosine kinase activity;response to radiation;signal transduction;stem cell factor receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase	Kit Receptor,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
3845	KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog	NM_004985, NM_033360	NP_004976.2, NP_203524.1	ENSG00000133703	chr12:25259641 - 25289585	GTP binding;GTPase activity;intracellular;membrane;nucleotide binding;protein binding;regulation of progression through cell cycle;sensory perception of sound;small GTPase mediated signal transduction	EGFR1,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Entrez Query:Oncogene,  Missense mutation
6416	MAP2K4	mitogen-activated protein kinase kinase 4	NM_003010	NP_003001.1	ENSG00000065559	chr17:11864928 - 11985302	ATP binding;JNK cascade;nucleotide binding;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;protein-tyrosine kinase activity;signal transduction;transferase activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Large deletion,  Missense mutation,  Nonsense mutation
4193	MDM2	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse)	NM_006881, NM_006878, NM_006882, NM_002392, NM_006879	NP_006872.3, NP_006869.3, NP_006873.3, NP_002383.2, NP_006870.3	ENSG00000135679	chr12:67488524 - 67519896	enzyme binding;intracellular;ligase activity;metal ion binding;negative regulation of cell proliferation;negative regulation of transcription from RNA polymerase II promoter;negative regulator of basal transcription activity;nucleolus;nucleoplasm;nucleus;protein binding;protein complex assembly;protein ubiquitination;regulation of progression through cell cycle;regulation of protein catabolic process;ubiquitin-protein ligase activity;zinc ion binding	Androgen Receptor,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene
4221	MEN1	multiple endocrine neoplasia I	NM_130802, NM_130799	NP_570716.1, NP_570711.1	ENSG00000133895	chr11:64328381 - 64334157	cleavage furrow;cytosol;DNA binding;histone methylation;histone methyltransferase complex;negative regulation of transcription from RNA polymerase II promoter;nucleus;positive regulation of transcription;protein binding;regulation of transcription, DNA-dependent;transcription regulator activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4233	MET	met proto-oncogene (hepatocyte growth factor receptor)	NM_001127500, NM_000245	NP_001120972.1, NP_000236.2	ENSG00000105976	chr7:116126374 - 116223414	activation of MAPK activity;adult behavior;ATP binding;basal plasma membrane;brain development;cell surface receptor linked signal transduction;hepatocyte growth factor receptor activity;hepatocyte growth factor receptor signaling pathway;integral to plasma membrane;membrane;membrane fraction;multicellular organismal development;muscle development;myoblast proliferation;nucleotide binding;protein amino acid autophosphorylation;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activi	Alpha6Beta4 Integrin,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Missense mutation
4292	MLH1	mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)	NM_000249	NP_000240.1	ENSG00000076242	chr3:37010042 - 37067148	ATP binding;cell cycle;guanine/thymine mispair binding;mismatch repair;mismatched DNA binding;MutSalpha complex binding;negative regulation of progression through cell cycle;nucleus;protein binding;single-stranded DNA binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4297	MLL	myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)	NM_005933	NP_005924.2	ENSG00000118058	chr11:117812437 - 117898097	anterior/posterior pattern formation;ATP binding;DNA binding;DNA methylation;embryonic hemopoiesis;metal ion binding;nuclear part;protein amino acid phosphorylation;protein binding;protein complex assembly;protein homodimerization activity;protein kinase activity;regulation of histone H3-K4 methylation;regulation of transcription, DNA-dependent;RNA polymerase II transcription factor activity;transcription;transcription factor activity;transcription from RNA polymerase II promoter;zinc ion binding	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Translocation
4436	MSH2	mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli)	NM_000251	NP_000242.1	ENSG00000095002	chr2:47483834 - 47563592	ADP binding;apoptosis;ATP binding;ATPase activity;B cell differentiation;B cell mediated immunity;base-excision repair;cell cycle;cell cycle arrest;cell motility;centromeric DNA binding;damaged DNA binding;determination of adult life span;dinucleotide repeat insertion binding;four-way junction DNA binding;guanine/thymine mispair binding;hypoxanthine phosphoribosyltransferase activity;in utero embryonic development;intra-S DNA damage checkpoint;isotype switching;magnesium ion binding;maintenance of DNA repea	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
2956	MSH6	mutS homolog 6 (E. coli)	NM_000179	NP_000170.1	ENSG00000116062	chr2:47863876 - 47887503	ADP binding;ATP binding;ATPase activity;base-excision repair;chromatin binding;damaged DNA binding;determination of adult life span;dinucleotide insertion or deletion binding;DNA damage response, signal transduction resulting in induction of apoptosis;four-way junction DNA binding;guanine/thymine mispair binding;isotype switching;magnesium ion binding;mismatch repair;mismatched DNA binding;MutLalpha complex binding;MutSalpha complex;negative regulation of DNA recombination;nuclear chromatin;nucleotide bindi	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
4595	MUTYH	mutY homolog (E. coli)	NM_001048172, NM_001128425, NM_001048173, NM_012222	NP_001041637.1, NP_001121897.1, NP_001041639.1, NP_036354.1	ENSG00000132781	chr1:45567564 - 45572764	4 iron, 4 sulfur cluster binding;base-excision repair;cell cycle;DNA binding;DNA N-glycosylase activity;endonuclease activity;hydrolase activity;hydrolase activity, acting on glycosyl bonds;intracellular;iron ion binding;metabolic process;metal ion binding;mismatch repair;MutLalpha complex binding;MutLbeta complex binding;MutSalpha complex binding;MutSbeta complex binding;negative regulation of progression through cell cycle;nucleus;protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Missense mutation
4609	MYC	v-myc myelocytomatosis viral oncogene homolog (avian)	NM_002467	NP_002458.2	ENSG00000136997	chr8:128818021 - 128822386	activation of pro-apoptotic gene products;caspase activation;cell cycle arrest;DNA binding;DNA fragmentation during apoptosis;induction of apoptosis by intracellular signals;iron ion homeostasis;negative regulation of survival gene product activity;nucleus;positive regulation of cell proliferation;protein binding;regulation of apoptosis;regulation of transcription from RNA polymerase II promoter;regulation of transcription, DNA-dependent;release of cytochrome c from mitochondria;response to radiation;spindl	EGFR1,  TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Amplification,  Translocation
4610	MYCL1	v-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)	NM_001033081, NM_005376	NP_001028254.1, NP_005367.1	ENSG00000116990	chr1:40135630 - 40139693	nucleus;regulation of transcription, DNA-dependent;transcription factor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Amplification
4613	MYCN	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)	NM_005378	NP_005369.2	ENSG00000134323	chr2:15999637 - 16003670	branching morphogenesis of a tube;chromatin;lung development;nucleus;positive regulation of cell proliferation;protein binding;regulation of transcription from RNA polymerase II promoter;transcription factor activity	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Amplification
4683	NBN	nibrin			ENSG00000104320	chr8:null	blastocyst growth;cell cycle;cell cycle arrest;cell proliferation;chromosome;chromosome, telomeric region;damaged DNA binding;DNA damage checkpoint;DNA damage response, signal transduction by p53 class mediator;double-strand break repair;G1/S transition checkpoint;in utero embryonic development;intracellular;isotype switching;meiosis;mitotic G2 checkpoint;Mre11 complex;nuclear inclusion body;nucleus;protein N-terminus binding;regulation of balance;regulation of DNA replication initiation;replication fork;te	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
4763	NF1	neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease)	NM_000267, NM_001042492, NM_001128147	NP_000258.1, NP_001035957.1, NP_001121619.1	ENSG00000196712	chr17:26446453 - 26725299	adrenal gland development;biological_process;cell cycle;cellular_component;cytoplasm;enzyme inhibitor activity;GTPase activator activity;heart development;intracellular;molecular_function;negative regulation of cell migration;negative regulation of endothelial cell proliferation;negative regulation of MAPKKK cascade;negative regulation of progression through cell cycle;positive regulation of Ras GTPase activity;protein binding;Ras GTPase activator activity;Ras protein signal transduction;regulation of glial	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4771	NF2	neurofibromin 2 (bilateral acoustic neuroma)	NM_181832, NM_000268, NM_181828, NM_181829, NM_181833, NM_181830	NP_861970.1, NP_000259.1, NP_861966.1, NP_861967.1, NP_861971.1, NP_861969.1	ENSG00000186575	chr22:28329987 - 28420791	cell cycle;cytoplasm;cytoskeletal protein binding;cytoskeleton;negative regulation of cell proliferation;negative regulation of progression through cell cycle;nucleus;plasma membrane;sensory perception of sound;structural molecule activity	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
4851	NOTCH1	Notch homolog 1, translocation-associated (Drosophila)	NM_017617	NP_060087.3	null	chr9:138510343 - 138560059	calcium ion binding;cell differentiation;immune response;integral to membrane;membrane;multicellular organismal development;negative regulation of myoblast differentiation;Notch signaling pathway;nucleus;protein binding;receptor activity;regulation of developmental process;regulation of transcription, DNA-dependent	NOTCH,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Missense mutation,  Translocation
4914	NTRK1	neurotrophic tyrosine kinase, receptor, type 1	NM_001012331, NM_002529, NM_001007792	NP_001012331.1, NP_002520.2, NP_001007793.1	ENSG00000198400	chr1:155097350 - 155118058	ATP binding;B cell differentiation;biological_process;cellular_component;cytoplasm;integral to membrane;integral to plasma membrane;kinase activity;mechanoreceptor differentiation;membrane;multicellular organismal development;nervous system development;neurotrophin binding;nucleotide binding;protein amino acid phosphorylation;protein binding;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase signaling pathway	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Translocation
4916	NTRK3	neurotrophic tyrosine kinase, receptor, type 3	NM_002530, NM_001007156, NM_001012338	NP_002521.2, NP_001007157.1, NP_001012338.1	ENSG00000140538	chr15:86221169 - 86600388	ATP binding;cell differentiation;integral to plasma membrane;membrane;multicellular organismal development;nervous system development;neurotrophin binding;nucleotide binding;protein amino acid phosphorylation;protein binding;protein-tyrosine kinase activity;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase signaling pathway	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tyrosine Kinase,  Translocation
5155	PDGFB	platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)	NM_002608, NM_033016	NP_002599.1, NP_148937.1	ENSG00000100311	chr22:37951673 - 37969914	cell proliferation;extracellular region;growth factor activity;membrane;platelet-derived growth factor receptor binding;regulation of progression through cell cycle;response to wounding	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Translocation
5156	PDGFRA	platelet-derived growth factor receptor, alpha polypeptide	NM_006206	NP_006197.1	ENSG00000134853	chr4:54819692 - 54856196	ATP binding;cell proliferation;cell surface receptor linked signal transduction;extracellular matrix organization and biogenesis;integral to plasma membrane;lung development;male genitalia development;membrane;nucleotide binding;odontogenesis (sensu Vertebrata);organ morphogenesis;platelet-derived growth factor alpha-receptor activity;platelet-derived growth factor binding;protein amino acid phosphorylation;receptor activity;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathw	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tyrosine Kinase,  Missense mutation,  Translocation
5159	PDGFRB	platelet-derived growth factor receptor, beta polypeptide	NM_002609	NP_002600.1	ENSG00000113721	chr5:149475518 - 149496803	ATP binding;integral to membrane;membrane;nucleotide binding;platelet activating factor receptor activity;platelet-derived growth factor receptor activity;protein amino acid phosphorylation;protein binding;receptor activity;regulation of peptidyl-tyrosine phosphorylation;signal transduction;transferase activity;transmembrane receptor protein tyrosine kinase signaling pathway;vascular endothelial growth factor receptor activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tyrosine Kinase,  Translocation
5395	PMS2	PMS2 postmeiotic segregation increased 2 (S. cerevisiae)	NM_000535	NP_000526.1	ENSG00000122512	chr7:5979555 - 6015176	ATP binding;cell cycle;DNA binding;mismatch repair;mismatched DNA binding;MutSalpha complex binding;negative regulation of progression through cell cycle;nucleus;protein binding;single base insertion or deletion binding;single-stranded DNA binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Frameshift mutation,  Missense mutation,  Nonsense mutation
5727	PTCH1	patched homolog 1 (Drosophila)	NM_000264, NM_001083602, NM_001083603	NP_001077076.1, NP_001077071.1, NP_001077072.1	ENSG00000185920	chr9:97249014 - 97310464	cell cycle;cell proliferation;dorsal/ventral pattern formation;embryonic limb morphogenesis;hedgehog receptor activity;integral to membrane;integral to plasma membrane;membrane;negative regulation of body size;negative regulation of progression through cell cycle;organ morphogenesis;protein binding;protein processing;receptor activity;regulation of smoothened activity;signal transduction;smoothened signaling pathway	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
5728	PTEN	phosphatase and tensin homolog (mutated in multiple advanced cancers 1)	NM_000314	NP_000305.3	ENSG00000171862	chr10:89614206 - 89715209	cell cycle;cell migration;cell proliferation;central nervous system development;cytoplasm;heart development;hydrolase activity;induction of apoptosis;inositol phosphate dephosphorylation;inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity;lipid binding;lipid metabolic process;negative regulation of apoptosis;negative regulation of cell migration;negative regulation of cell proliferation;negative regulation of focal adhesion formation;negative regulation of progression through cell cycle;negative regul	Androgen Receptor,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
5914	RARA	retinoic acid receptor, alpha	NM_001024809, NM_000964	NP_001019980.1, NP_000955.1	ENSG00000131759	chr17:35740996 - 35766004	metal ion binding;nucleus;protein binding;regulation of transcription, DNA-dependent;retinoic acid receptor activity;sequence-specific DNA binding;signal transduction;steroid hormone receptor activity;transcription;transcription coactivator activity;transcription factor activity;zinc ion binding	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Translocation
5925	RB1	retinoblastoma 1 (including osteosarcoma)	NM_000321	NP_000312.2	ENSG00000139687	chr13:47776049 - 47952208	androgen receptor binding;androgen receptor signaling pathway;cell cycle;cell cycle checkpoint;chromatin;chromatin modification;G1 phase;kinase binding;M phase;molecular_function;negative regulation of cell growth;negative regulation of progression through cell cycle;negative regulation of protein kinase activity;negative regulation of transcription from RNA polymerase II promoter;nucleus;PML body;positive regulation of transcription, DNA-dependent;protein binding;regulation of lipid kinase activity;regulat	Androgen Receptor,  ID,  TGFBR,  Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
9401	RECQL4	RecQ protein-like 4	NM_004260	NP_004251.2	ENSG00000160957	chr8:145707621 - 145713976	ATP binding;ATP-dependent helicase activity;DNA helicase activity;DNA recombination;DNA repair;hydrolase activity;multicellular organismal development;nucleic acid binding;nucleotide binding;nucleus;zinc ion binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Nonsense mutation,  Splicing mutation
5979	RET	ret proto-oncogene	NM_020630, NM_020975	NP_065681.1, NP_066124.1	ENSG00000165731	chr10:42892712 - 42943723	ATP binding;calcium ion binding;cell surface receptor linked signal transduction;homophilic cell adhesion;integral to membrane;kinase activity;membrane;nucleotide binding;posterior midgut development;protein amino acid phosphorylation;protein-tyrosine kinase activity;receptor activity;signal transduction;transferase activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Tyrosine Kinase,  Entrez Query:Oncogene,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Translocation
861	RUNX1	runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)	NM_001754, NM_001001890, NM_001122607	NP_001745.2, NP_001001890.1, NP_001116079.1	ENSG00000159216	chr21:35086301 - 35343066	ATP binding;biological_process;cellular_component;chloride ion binding;hemopoiesis;molecular_function;multicellular organismal development;nucleus;positive regulation of angiogenesis;positive regulation of granulocyte differentiation;positive regulation of transcription from RNA polymerase II promoter;protein binding;regulation of transcription, DNA-dependent;transcription;transcription factor activity;transcriptional activator activity	Androgen Receptor,  Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Translocation
6390	SDHB	succinate dehydrogenase complex, subunit B, iron sulfur (Ip)	NM_003000	NP_002991.2	ENSG00000117118	chr1:17217962 - 17253101	2 iron, 2 sulfur cluster binding;3 iron, 4 sulfur cluster binding;4 iron, 4 sulfur cluster binding;electron carrier activity;electron transport;iron ion binding;membrane;metal ion binding;mitochondrial inner membrane;mitochondrion;succinate dehydrogenase (ubiquinone) activity;transport;tricarboxylic acid cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation
6391	SDHC	succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa	NM_001089593, NM_001035513, NM_003001, NM_001035511	NP_001083062.1, NP_001030590.1, NP_002992.1, NP_001030588.1	ENSG00000143252	chr1:159550819 - 159598847	electron transport;integral to membrane;iron ion binding;membrane;metal ion binding;mitochondrion;respiratory chain complex II;succinate dehydrogenase activity;transport;tricarboxylic acid cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Frameshift mutation,  Missense mutation,  Nonsense mutation
6392	SDHD	succinate dehydrogenase complex, subunit D, integral membrane protein	NM_003002	NP_002993.1	null	chr11:111462841 - 111470904	electron carrier activity;electron transport;heme binding;integral to membrane;iron ion binding;membrane;metal ion binding;mitochondrial envelope;mitochondrial inner membrane;mitochondrion;succinate dehydrogenase activity;transport;tricarboxylic acid cycle	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
4087	SMAD2	SMAD family member 2	NM_001003652	NP_005892.1	ENSG00000175387	chr18:43622195 - 43677125	anterior/posterior pattern formation;cell fate commitment;double-stranded DNA binding;intracellular;intracellular signaling cascade;mesoderm formation;nucleus;paraxial mesoderm morphogenesis;positive regulation of transcription from RNA polymerase II promoter;regulation of binding;transcription;transcription factor binding;transcription factor complex;transcriptional activator activity;transforming growth factor beta receptor signaling pathway	Alpha6Beta4 Integrin,  EGFR1,  TGFBR,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor
4089	SMAD4	SMAD family member 4	NM_005359	NP_005350.1	ENSG00000141646	chr18:46827414 - 46858835	anterior/posterior pattern formation;cytoplasm;gastrulation (sensu Mammalia);intracellular;kidney development;negative regulation of cell proliferation;nucleus;positive regulation of transcription from RNA polymerase II promoter;protein binding;regulation of binding;SMAD protein complex assembly;transcription;transcription cofactor activity;transcription factor activity;transcription factor complex;transcriptional activator activity;ureteric bud branching	Androgen Receptor,  NOTCH,  TGFBR,  Wnt,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation
6760	SS18	synovial sarcoma translocation, chromosome 18	NM_005637, NM_001007559	NP_005628.2, NP_001007560.1	ENSG00000141380	chr18:21852315 - 21924531	nucleus	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Entrez Query:Oncogene,  Translocation
6794	STK11	serine/threonine kinase 11	NM_000455	NP_000446.1	ENSG00000118046	chr19:1157912 - 1177646	ATP binding;cell cycle;cell cycle arrest;cytoplasm;magnesium ion binding;manganese ion binding;nucleotide binding;nucleus;protein amino acid phosphorylation;protein binding;protein serine/threonine kinase activity;transferase activity	TGFBR,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
51684	SUFU	suppressor of fused homolog (Drosophila)	NM_016169	NP_057253.2	ENSG00000107882	chr10:104253899 - 104379902	cell cycle;cytoplasm;identical protein binding;multicellular organismal development;negative regulation of progression through cell cycle;nucleus;proteolysis;regulation of transcription, DNA-dependent;signal transducer activity;signal transduction;skeletal development;transcription corepressor activity	Hedgehog,  Futreal et al 2004,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Splicing mutation
6886	TAL1	T-cell acute lymphocytic leukemia 1	NM_003189	NP_003180.1	ENSG00000162367	chr1:47457978 - 47464147	cell fate commitment;cell proliferation;DNA binding;erythrocyte differentiation;hemopoiesis;multicellular organismal development;nucleus;protein binding;regulation of transcription;regulation of transcription, DNA-dependent;transcription regulator activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
7030	TFE3	transcription factor binding to IGHM enhancer 3	NM_006521	NP_006512.2	ENSG00000068323	chrX:48774612 - 48787696	nucleus;protein binding;regulation of transcription, DNA-dependent;transcription factor activity;transcription from RNA polymerase II promoter	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
7046	TGFBR1	transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kDa)	NM_004612	NP_004603.1	ENSG00000106799	chr9:100907308 - 100951408	ATP binding;integral to membrane;integral to plasma membrane;magnesium ion binding;manganese ion binding;membrane;nucleotide binding;positive regulation of cell proliferation;protein amino acid phosphorylation;receptor activity;regulation of transcription;signal transduction;SMAD binding;transferase activity;transforming growth factor beta binding;transforming growth factor beta receptor activity;transforming growth factor beta receptor activity, type I;transforming growth factor beta receptor complex assem	TGFBR,  Vogelstein and Kinzler 2004,  Stability
7048	TGFBR2	transforming growth factor, beta receptor II (70/80kDa)	NM_001024847, NM_003242	NP_001020018.1, NP_003233.4	ENSG00000163513	chr3:30623379 - 30708095	ATP binding;integral to membrane;magnesium ion binding;manganese ion binding;membrane;nucleotide binding;positive regulation of cell proliferation;protein amino acid phosphorylation;protein binding;receptor activity;transferase activity;transforming growth factor beta receptor activity, type II;transmembrane receptor protein serine/threonine kinase signaling pathway	TGFBR,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability
3195	TLX1	T-cell leukemia homeobox 1	NM_005521	NP_005512.1	ENSG00000107807	chr10:102881288 - 102886660	cell fate commitment;central nervous system development;multicellular organismal development;neuron differentiation;nucleus;organ formation;positive regulation of cell proliferation;positive regulation of transcription from RNA polymerase II promoter;protein heterodimerization activity;regulation of transcription, DNA-dependent;sequence-specific DNA binding;spleen development;transcription factor activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Entrez Query:Oncogene,  Translocation
30012	TLX3	T-cell leukemia homeobox 3	NM_021025	NP_066305.2	ENSG00000164438	chr5:170668974 - 170671208	central nervous system development;multicellular organismal development;negative regulation of neuron differentiation;neuron differentiation;neuron fate specification;neuron migration;nucleus;protein binding;regulation of transcription, DNA-dependent;respiratory gaseous exchange;sequence-specific DNA binding;transcription factor activity	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Translocation
7157	TP53	tumor protein p53 (Li-Fraumeni syndrome)	NM_001126114, NM_001126117, NM_000546, NM_001126113, NM_001126112, NM_001126116	NP_001119586.1, NP_001119589.1, NP_001119587.1, NP_001119585.1, NP_001119584.1, NP_001119588.1	ENSG00000141510	chr17:7513651 - 7520637	ATP binding;base-excision repair;caspase activation via cytochrome c;cell aging;cell cycle;cell cycle arrest;cell differentiation;cell proliferation;cellular response to glucose starvation;copper ion binding;cytoplasm;DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis;DNA strand annealing activity;endoplasmic reticulum;enzyme binding;ER overload response;induction of apoptosis by intracellular signals;insoluble fraction;metal ion binding;mitochondrion;multicel	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Missense mutation,  Nonsense mutation
7248	TSC1	tuberous sclerosis 1	NM_000368, NM_001008567	NP_000359.1, NP_001008567.1	ENSG00000165699	chr9:134761442 - 134794080	cell adhesion;cell cycle;negative regulation of progression through cell cycle;Rho protein signal transduction	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7249	TSC2	tuberous sclerosis 2	NM_001114382, NM_001077183, NM_000548	NP_001107854.1, NP_001070651.1, NP_000539.2	ENSG00000103197	chr16:2038617 - 2078612	cell cycle;cytoplasm;cytosol;endocytosis;GTPase activator activity;intracellular;membrane fraction;negative regulation of progression through cell cycle;plasma membrane;positive regulation of GTPase activity;protein folding;regulation of small GTPase mediated signal transduction;unfolded protein binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Protein Kinase,  Stability,  Tumor Suppressor,  Entrez Query:Oncogene,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7428	VHL	von Hippel-Lindau tumor suppressor	NM_198156, NM_000551	NP_937799.1, NP_000542.1	ENSG00000134086	chr3:10158531 - 10166649	anti-apoptosis;cell cycle;cell morphogenesis;cytosol;endoplasmic reticulum;mitochondrion;negative regulation of cell proliferation;negative regulation of progression through cell cycle;negative regulation of transcription from RNA polymerase II promoter;nucleus;positive regulation of cell differentiation;protein stabilization;protein ubiquitination;proteolysis;response to stress;transcription factor binding	Futreal et al 2004,  Hahn and Weinberg 2002,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7486	WRN	Werner syndrome	NM_000553	NP_000544.2	ENSG00000165392	chr8:31035505 - 31150160	3'-5' exonuclease activity;aging;ATP binding;ATP-dependent helicase activity;DNA binding;DNA helicase activity;DNA recombination;hydrolase activity;intracellular;nucleotide binding;nucleus;protein binding;regulation of growth rate;telomere maintenance	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Tumor Suppressor,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
7490	WT1	Wilms tumor 1	NM_000378, NM_024424, NM_024426, NM_024425	NP_000369.3, NP_077742.2, NP_077744.3, NP_077743.2	ENSG00000184937	chr11:32367179 - 32413467	cell cycle;intracellular;metal ion binding;negative regulation of progression through cell cycle;nucleic acid binding;nucleus;regulation of transcription, DNA-dependent;transcription;transcription factor activity;zinc ion binding	Futreal et al 2004,  Mitelman 2000,  Vogelstein and Kinzler 2004,  Tumor Suppressor,  Frameshift mutation,  Large deletion,  Missense mutation,  Nonsense mutation,  Splicing mutation
7507	XPA	xeroderma pigmentosum, complementation group A	NM_000380	NP_000371.1	ENSG00000136936	chr9:99477541 - 99499395	damaged DNA binding;metal ion binding;nucleotide-excision repair;nucleus;protein binding;zinc ion binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
7508	XPC	xeroderma pigmentosum, complementation group C	NM_004628	NP_004619.3	ENSG00000154767	chr3:14162441 - 14195072	damaged DNA binding;nucleotide-excision repair;nucleus;protein binding;single-stranded DNA binding	Futreal et al 2004,  Vogelstein and Kinzler 2004,  Stability,  Frameshift mutation,  Missense mutation,  Nonsense mutation,  Splicing mutation
